Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Akhiani, Ali A ^a   Werlenius, Olle ^a   Aurelius, Johan ^a   Movitz, Charlotta ^a   Martner, Anna ^a   Hellstrand, Kristoffer ^a   Thorén, Fredrik B ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MOLECULAR DYNAMICS; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PURIFICATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; HYDROGEN PEROXIDE; KILLER CELLS, NATURAL; MAP KINASE SIGNALING SYSTEM; OXIDANTS; OXIDATIVE STRESS; PHOSPHORYLATION; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES;

EID: 84896777334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089646     Document Type: Article

References (61)

1. Klebanoff SJ (1999) Oxygen Metabolites from Phagocytes. In: Gallin JI, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. Philadelphia: Lippincott Williams & Wilkins. 721-768.
2. Hansson M, Asea A, Ersson U, Hermodsson S, Hellstrand K (1996) Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 156: 42-47. (Pubitemid 26006946)
3. Harlin H, Hanson M, Johansson CC, Sakurai D, Poschke I, et al. (2007) The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol 179: 4513-4519.
4. Thoren FB, Romero AI, Hellstrand K (2006) Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes. J Immunol 176: 7301-7307. (Pubitemid 43849030)
5. Thoren FB, Betten A, Romero AI, Hellstrand K (2007) Cutting edge: Antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J Immunol 179: 21-25. (Pubitemid 46986511)
6. Martner A, Aurelius J, Rydstrom A, Hellstrand K, Thoren FB (2011) Redox remodeling by dendritic cells protects antigen-specific T cells against oxidative stress. J Immunol 187: 6243-6248.
7. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, et al. (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33: 25-32. (Pubitemid 36068678)
8. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646-12651. (Pubitemid 39122077)
9. Mellqvist UH, Hansson M, Brune M, Dahlgren C, Hermodsson S, et al. (2000) Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968. (Pubitemid 30661084)
10. Aurelius J, Thoren FB, Akhiani AA, Brune M, Palmqvist L, et al. (2012) Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis. Blood 119: 5832-5837.
11. Kono K, Ressing ME, Brandt RM, Melief CJ, Potkul RK, et al. (1996) Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 2: 1825-1828. (Pubitemid 26384148)
12. Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM, et al. (1996) Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin Cancer Res 2: 1263-1274. (Pubitemid 26299423)
13. Healy CG, Simons JW, Carducci MA, DeWeese TL, Bartkowski M, et al. (1998) Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry 32: 109-119. (Pubitemid 28246758)
14. Buggins AG, Hirst WJ, Pagliuca A, Mufti GJ (1998) Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies. Br J Haematol 100: 784-792. (Pubitemid 28126116)
15. Hellstrand K (2003) Melanoma immunotherapy: a battle against radicals? Trends Immunol 24: 232-233; author reply 234.
16. Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjoberg J, et al. (1999) Tumor-induced immune dysfunction. Cancer Immunol Immunother 48: 353-362. (Pubitemid 29461387)
17. Schmielau J, Nalesnik MA, Finn OJ (2001) Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. Clin Cancer Res 7: 933s-939s. (Pubitemid 33600948)
18. Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T (1996) Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of Tcell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A 93: 13119-13124. (Pubitemid 26382779)
19. Martner A, Thoren FB, Aurelius J, Soderholm J, Brune M, et al. (2010) Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia. Expert Rev Hematol 3: 381-391.
20. Romero AI, Thoren FB, Aurelius J, Askarieh G, Brune M, et al. (2009) Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML. Scand J Immunol 70: 194-205.
21. Brune M, Castaigne S, Catalano J, Gehlsen K, Ho AD, et al. (2006) Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial. Blood 108: 88-96. (Pubitemid 43996626)
22. Bouchard VJ, Rouleau M, Poirier GG (2003) PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol 31: 446-454. (Pubitemid 36793950)
23. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-1095. (Pubitemid 27444449)
24. Yu SW, Wang H, Dawson TM, Dawson VL (2003) Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 14: 303-317. (Pubitemid 37543510)
25. Alano CC, Ying W, Swanson RA (2004) Poly(ADP-ribose) polymerase-1- mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 279: 18895-18902. (Pubitemid 38623317)
26. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, et al. (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci U S A 103: 18314-18319. (Pubitemid 44871655)
27. Wang Y, Dawson VL, Dawson TM (2009) Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 218: 193-202.
28. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19: 107-120.
29. Waskiewicz AJ, Cooper JA (1995) Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 7: 798-805.
30. Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186. (Pubitemid 27135985)
31. Obata T, Brown GE, Yaffe MB (2000) MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 28: N67-77.
32. Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55-72. (Pubitemid 34293420)
33. Ramos JW (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40: 2707-2719.
34. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ (1996) Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271: 4138-4142.
35. Wang X, Martindale JL, Liu Y, Holbrook NJ (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333 (Pt 2): 291-300. (Pubitemid 28379529)
36. Bhat NR, Zhang P (1999) Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J Neurochem 72: 112-119. (Pubitemid 29013884)
37. Brand A, Gil S, Seger R, Yavin E (2001) Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation. J Neurochem 76: 910-918. (Pubitemid 32126091)
38. Ishikawa Y, Kitamura M (2000) Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 58: 1078-1087.
39. Lee WC, Choi CH, Cha SH, Oh HL, Kim YK (2005) Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30: 263-270. (Pubitemid 40569210)
40. Ma C, Bower KA, Chen G, Shi X, Ke ZJ, et al. (2008) Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells. J Biol Chem 283: 9248-9256.
41. Gutierrez-Venegas G, Arreguin-Cano JA, Arroyo-Cruz R, Villeda-Navarro M, Mendez-Mejia JA (2010) Activation of ERK1/2 by protein kinase C-alpha in response to hydrogen peroxide-induced cell death in human gingival fibroblasts. Toxicol In Vitro 24: 319-326.
42. Romero AI, Thoren FB, Brune M, Hellstrand K (2006) NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species. Br J Haematol 132: 91-98. (Pubitemid 43381575)
43. Fatokun AA, Stone TW, Smith RA (2007) Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures. Neurosci Lett 416: 34-38. (Pubitemid 46428008)
44. Shimizu Y, DeMars R (1989) Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol 142: 3320-3328. (Pubitemid 19129961)
45. Dahlgren C, Karlsson A (1999) Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14. (Pubitemid 30017761)
46. Oh P-S, Lim K-T (2008) Protective activity of 30 kDa phytoglycoprotein from glucose/glucose oxidase-induced cell death in primary cultured mouse thymocytes. Environmental Toxicology and Pharmacology 25: 114-120. (Pubitemid 350199011)
47. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11: 36-42.
48. Kondadasula SV, Varker KA, Lesinski GB, Benson DM Jr, Lehman A, et al. (2008) Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay. Cancer Immunol Immunother 57: 1137-1149.
49. Karlsson A, Nixon JB, McPhail LC (2000) Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol 67: 396-404.
50. Hellstrand K, Asea A, Dahlgren C, Hermodsson S (1994) Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol 153: 4940-4947. (Pubitemid 24356125)
51. Hellstrand K, Asea A, Hermodsson S (1994) Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells. J Leukoc Biol 55: 392-397. (Pubitemid 24097247)
52. Durkacz BW, Omidiji O, Gray DA, Shall S (1980) (ADP-ribose)n participates in DNA excision repair. Nature 283: 593-596. (Pubitemid 10136042)
53. Alvarez-Gonzalez R, Althaus FR (1989) Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents. Mutat Res 218: 67-74. (Pubitemid 19227629)
54. Reth M (2002) Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3: 1129-1134.
55. Rhee SG (2006) Cell signaling. H2O2, a necessary evil for cell signaling. Science 312: 1882-1883.
56. McCubrey JA, Lahair MM, Franklin RA (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8: 1775-1789. (Pubitemid 44726351)
57. Cohen-Armon M, Visochek L, Rozensal D, Kalal A, Geistrikh I, et al. (2007) DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell 25: 297-308. (Pubitemid 46127778)
58. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
59. Aurelius J, Martner A, Brune M, Palmqvist L, Hansson M, et al. (2012) Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells. Haematologica 97: 1904-1908.
60. Aurelius J, Martner A, Riise RE, Romero AI, Palmqvist L, et al. (2013) Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes. J Leukoc Biol 93: 155-160.
61. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Masucci G, et al. (1996) Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol 26: 1308-1313.